NewsRx

Search our medical news database

Toxoplasmosis

Immune CD8+ T Cells Prevent Reactivation of T. gondii

Published in AIDS Weekly, December 13th, 1999

Immune CD8+ T cells can be used to prevent reactivation of Toxoplasma gondii infection in immunosuppressed patients, researchers from the United States suggest.

T. gondii infection is a serious cause of morbidity and mortality in immunocompromised patients, especially patients with AIDS. The host's cellular immune response is an essential component in providing protective immunity against this parasite. The immune response initiated by gamma interferon (IFNgamma)-producing CD8+ T cells is especially important in this process.

Imtiaz A. Khan and colleagues from the Dartmouth Medical School, New Hampshire,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook